De Schutter H - Search Results

1

A new approach to the validation of tissue microarrays.

Goethals L, Perneel C, Debucquoy A, De Schutter H, Borghys D, Ectors N, Geboes K, McBride WH, Haustermans KM. Goethals L, et al. Among authors: de schutter h. J Pathol. 2006 Apr;208(5):607-14. doi: 10.1002/path.1934. J Pathol. 2006. PMID: 16435284

2

The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy.

De Schutter H, Landuyt W, Verbeken E, Goethals L, Hermans R, Nuyts S. De Schutter H, et al. BMC Cancer. 2005 Apr 25;5:42. doi: 10.1186/1471-2407-5-42. BMC Cancer. 2005. PMID: 15847702 Free PMC article.

3

Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.

Goethals L, Debucquoy A, Perneel C, Geboes K, Ectors N, De Schutter H, Penninckx F, McBride WH, Begg AC, Haustermans KM. Goethals L, et al. Among authors: de schutter h. Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):246-54. doi: 10.1016/j.ijrobp.2006.01.007. Int J Radiat Oncol Biol Phys. 2006. PMID: 16618579

4

Microsatellite alterations in head and neck squamous cell carcinoma and relation to expression of pimonidazole, CA IX and GLUT-1.

De Schutter H, Barbé B, Spaepen M, Begg AC, Balm A, Gregoire V, Haustermans K, Mahy P, Vander Poorten V, Nuyts S. De Schutter H, et al. Radiother Oncol. 2006 Aug;80(2):143-50. doi: 10.1016/j.radonc.2006.07.018. Epub 2006 Aug 17. Radiother Oncol. 2006. PMID: 16916559

5

The clinical relevance of microsatellite alterations in head and neck squamous cell carcinoma: a critical review.

De Schutter H, Spaepen M, Mc Bride WH, Nuyts S. De Schutter H, et al. Eur J Hum Genet. 2007 Jul;15(7):734-41. doi: 10.1038/sj.ejhg.5201845. Epub 2007 May 2. Eur J Hum Genet. 2007. PMID: 17473833 Review.

6

The prevalence of microsatellite instability in head and neck squamous cell carcinoma.

De Schutter H, Spaepen M, Van Opstal S, Vander Poorten V, Verbeken E, Nuyts S. De Schutter H, et al. J Cancer Res Clin Oncol. 2009 Mar;135(3):485-90. doi: 10.1007/s00432-008-0476-1. Epub 2008 Sep 26. J Cancer Res Clin Oncol. 2009. PMID: 18818948

7

Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.

De Schutter H, Geeraerts H, Verbeken E, Nuyts S. De Schutter H, et al. Oncol Rep. 2009 Feb;21(2):507-13. Oncol Rep. 2009. PMID: 19148529

8

Radiosensitizing potential of epigenetic anticancer drugs.

De Schutter H, Nuyts S. De Schutter H, et al. Anticancer Agents Med Chem. 2009 Jan;9(1):99-108. doi: 10.2174/187152009787047707. Anticancer Agents Med Chem. 2009. PMID: 19149485 Review.

9

A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma.

De Schutter H, Kimpe M, Isebaert S, Nuyts S. De Schutter H, et al. Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):904-12. doi: 10.1016/j.ijrobp.2008.10.032. Int J Radiat Oncol Biol Phys. 2009. PMID: 19215824

10

The use of transdermal buprenorphine to relieve radiotherapy-related pain in head and neck cancer patients.

Menten J, Carpentier I, Deschutter H, Nuyts S, Van Beek K. Menten J, et al. Cancer Invest. 2013 Jul;31(6):412-20. doi: 10.3109/07357907.2013.800094. Epub 2013 Jun 11. Cancer Invest. 2013. PMID: 23758187

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters